Publication:
Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab.

dc.contributor.authorGarcía-Guerrero, Estefanía
dc.contributor.authorGogishvili, Tea
dc.contributor.authorDanhof, Sophia
dc.contributor.authorSchreder, Martin
dc.contributor.authorPallaud, Celine
dc.contributor.authorPérez-Simón, Jose Antonio
dc.contributor.authorEinsele, Hermann
dc.contributor.authorHudecek, Michael
dc.date.accessioned2023-01-25T09:45:56Z
dc.date.available2023-01-25T09:45:56Z
dc.date.issued2017-05-05
dc.identifier.doi10.1182/blood-2017-03-770776
dc.identifier.essn1528-0020
dc.identifier.pmid28476749
dc.identifier.unpaywallURLhttps://ashpublications.org/blood/article-pdf/129/25/3386/1364427/blood770776.pdf
dc.identifier.urihttp://hdl.handle.net/10668/11177
dc.issue.number25
dc.journal.titleBlood
dc.journal.titleabbreviationBlood
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number3386-3388
dc.pubmedtypeLetter
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subject.meshADP-ribosyl Cyclase 1
dc.subject.meshAntibodies, Monoclonal
dc.subject.meshAntigens, Neoplasm
dc.subject.meshDose-Response Relationship, Drug
dc.subject.meshDrug Synergism
dc.subject.meshGene Expression Regulation, Neoplastic
dc.subject.meshHistone Deacetylase Inhibitors
dc.subject.meshHumans
dc.subject.meshHydroxamic Acids
dc.subject.meshIndoles
dc.subject.meshMembrane Glycoproteins
dc.subject.meshMultiple Myeloma
dc.subject.meshNeoplasm Proteins
dc.subject.meshPanobinostat
dc.subject.meshSignaling Lymphocytic Activation Molecule Family
dc.subject.meshTumor Cells, Cultured
dc.subject.meshUp-Regulation
dc.titlePanobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number129
dspace.entity.typePublication

Files